Loading organizations...
§ Private Profile · Hyderabad, Telangana, India
MedTech company offering wearable photobiomodulation devices for non-invasive pain relief of musculoskeletal conditions.
Based in Hyderabad, India, Curapod develops and sells wearable, non-invasive pain relief devices utilizing photobiomodulation and red light therapy to treat musculoskeletal conditions. The company operates a direct-to-consumer business model, offering FDA-registered and CDSCO-approved rechargeable devices designed for home use without pharmaceutical intervention or side effects. Operating with a team of 16 employees, the medical technology firm recently secured INR 20 crore, or approximately $2.2 million, in pre-Series A funding to scale manufacturing and expand its pan-India market presence. This recent investment round was backed by venture capital firms including V3 Ventures, 3i Partners, and Ideaspring Capital. Following a soft launch in late 2024, the company has reported 20% month-over-month revenue growth and is targeting a monthly revenue of INR 1 crore by July 2025. Curapod was founded in 2022 by Sri Velliyur and Surya Maguluri.
Curapod has raised $24.2M across 2 funding rounds.
Curapod has raised $24.2M in total across 2 funding rounds.
Curapod has raised $24.2M across 2 funding rounds. Most recently, it raised $22.0M Pre-Series A in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 10, 2026 | $22M Series A | 3I Partners, Ideaspring Capital, V3 Ventures | Litemed | Announced |
| Feb 10, 2026 | $2.2M Seed | 3I Partners, Ideaspring Capital, V3 Ventures | — | Announced |
Curapod has raised $24.2M in total across 2 funding rounds.
Curapod's investors include 3i Partners, Ideaspring Capital, V3 Ventures, Litemed, V3 ventures.